Evidence map›Paper›PMID 31915708›Full record

ArticleJournal of diabetes research2019

Myeloid-Derived Suppressor Cells Show Different Frequencies in Diabetics and Subjects with Arterial Hypertension.

Julio C Fernández-Ruiz, Julia C Galindo-De Ávila, Margarita L Martínez-Fierro, Idalia Garza-Veloz, Alberto R Cervantes-Villagrana, Monica A Valtierra-Alvarado, Carmen J Serrano, Mariana H García-Hernández, José A Enciso-Moreno, Julio E Castañeda-Delgado

Abstract read
In one paragraph

Article in Journal of diabetes research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Murine Models of Obesity-Related Cancer Risk.Cancer prevention research (Philadelphia, Pa.) · 2025
    Review
  3. Recent advances on immunity and hypertension: the new cells on the kidney block.American journal of physiology. Renal physiology · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julio C Fernández-RuizUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas, Mexico.ORCID https://orcid.org/0000-0002-5490-6049
Julia C Galindo-De ÁvilaUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas, Mexico.
Margarita L Martínez-FierroLaboratorio de Medicina Molecular, Unidad Académica de Medicina Humana y Ciencias de la Salud, Campus UAZ XXI, Universidad Autónoma de Zacatecas, Zacatecas, Mexico.
Idalia Garza-VelozLaboratorio de Medicina Molecular, Unidad Académica de Medicina Humana y Ciencias de la Salud, Campus UAZ XXI, Universidad Autónoma de Zacatecas, Zacatecas, Mexico.
Alberto R Cervantes-VillagranaUnidad Académica de Ciencias Químicas, Área de Ciencias de la Salud, Universidad Autónoma de Zacatecas, Zacatecas, Mexico.
Monica A Valtierra-AlvaradoUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas, Mexico.
Carmen J SerranoUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas, Mexico.
Mariana H García-HernándezUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas, Mexico.
José A Enciso-MorenoUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas, Mexico.
Julio E Castañeda-DelgadoUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas, Mexico.ORCID https://orcid.org/0000-0003-2124-2036

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (DM2) is strongly associated with other comorbidities such as obesity, atherosclerosis, and hypertension. Obesity is associated with sustained low-grade inflammatory response due to the production of proinflammatory cytokines. This inflammatory process promotes the differentiation of some myeloid cells, including myeloid-derived suppressor cells (MDSCs). In this study, two groups of individuals were included: DM2 patients and non-DM2 individuals with similar characteristics. Immunolabeling of CD15+ CD14- and CD33+ HLA-DR-/low was performed from whole peripheral blood, and samples were analyzed by flow cytometry, and frequencies of MDSCs and the relationship of these with clinical variables, cytokine profile (measured by cytometric bead array), and anthropometric variables were analyzed. The frequency of CD33+ HLA-DR-/low MDSCs (that produce IL-10 and TGF-

Indexed as

AdultDiabetes Mellitus, Type 2FemaleHLA-DR AntigensHumansHypertensionInterleukin-10Interleukin-5MaleMiddle AgedMyeloid-Derived Suppressor CellsSialic Acid Binding Ig-like Lectin 3Transforming Growth Factor betaCD33 protein, humanHLA-DR AntigensIL10 protein, humanInterleukin-10Interleukin-5Sialic Acid Binding Ig-like Lectin 3Transforming Growth Factor beta

Identifiers

PMID31915708
PMCPMC6930726

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.